Sandoz Canada is led by a diverse team with extensive experience in the pharmaceutical industry.
Mr. Robidoux began his career in sales and marketing at Bayer, where he worked for seven years. He then spent the next 13 years at Roche working as an executive in the Diabetes Care, Clinical Diagnostics molecular diagnostics and Applied Sciences Divisions.
He is an active contributor to the Canadian pharmaceutical industry as a member of the Canadian Generic Pharmaceutical Association (CGPA), Chair of Biosimilar Canada and a member of the Board of Directors of the Canadian Association of Pharmaceutical Supply Management (CAPDM).
Throughout his career, Mr. Robidoux placed the values of integrity, trust, innovation, teamwork and dedication at the heart of his approach to serving key clients such as hospitals, physicians, pharmacists, banners, distributors and governments.
Mr. Robidoux holds a Bachelor degree in Business Administration from the Université du Québec in Montreal and has an A.S.C. (certified company administrator) designation from the Collège des administrateurs de sociétés of Université Laval.
Under his leadership, Sandoz Canada has become a national leader in the commercialization of generic and biosimilar medicines. For three consecutive years, Sandoz Canada has been recognized as one of Canada’s best employers by the Top Employers Institute and Great Place to Work. In 2021, Sandoz Canada received Mercuriades awards in the Employer of the Year and Women’s Leadership categories.
Very involved in his field, Christian is a member of the C.D. Howe Institute’s Healthcare Policy Initiative and governor of the Regroupement des jeunes chambres de commerce du Québec (RJCCQ).
Christian holds an MBA from Université du Québec à Montréal (UQÀM) and Université Paris Dauphine, a Certificate in Organizational Leadership from HEC Montréal and a Bachelor’s degree in Administration.
He holds a bachelor’s degree in Marketing from HEC, which allowed him to discover different facets of administration, personnel management, product launch and national brand positioning.
Mr. Binet holds degrees in pharmacy and law
Ms. Matteau has over 20 years of experience in the pharmaceutical industry in strategic commercial positions. She joined Novartis in 2007 and over the last 13 years, she has successfully filled various commercial roles in a number of general medicine and specialty divisions, notably within the Novartis Oncology division. Prior to Novartis, she held various commercial positions at Sanofi-Aventis Canada, mainly in CV and Metabolism/Diabetes.
Karine Matteau’s academic background includes an MBA from HEC Montréal and a Bachelor of Science from McGill University.
Having joined Sandoz (previously Sabex) in 1997, Mr. St-Pierre has over 25 years' experience in the field of human resources management. He has previously held several management positions in industry-leading companies, more specifically in the publishing/direct mail business (with Reader's Digest) as well as telecommunications (with Canadian Marconi Company).
Mr. St-Pierre holds a Bachelor's degree in Industrial Relations from the Université du Québec en Outaouais and is a member of the Ordre des conseillers en ressources humaines agréés (CHRP).
Visit LinkedIn profile
Marie-Claude Hudon has been Vice President, Ethics, Risk and Compliance at Sandoz since June 2022, before which she served as Executive Director for almost a year. Lawyer and member of the Barreau du Québec, Marie-Claude has more than 20 years of experience with multinational GlaxoSmithKline, where she rose through the ranks to serve as Ethics and Compliance Manager for the last six years.
Very involved in her field, she has also been a presenter at events and trainings organized by the Canadian Bar Association, the Association of Corporate Legal Advisors, Quebec Chapter and Executive Education HEC Montreal in order to share her expertise.
Marie-Claude holds a postgraduate diploma in Health Law and Policies, a postgraduate diploma in Biomedical Ethics, a graduate diploma in Bioethics, and a Bachelor’s in Law.
Prior to Katz, M. Boehmer worked for several well-known pharmaceutical companies, including Merck Frosst Canada, Eli Lilly Canada and Schering Canada, before joining Patheon Inc. as Senior Manager, Pharmaceutical Development Services, in 1996. Over the following 15 years, he held increasingly senior positions with this leading global provider of outsourced drug development and manufacturing.
He holds a BSc (Chemistry) and Bachelor of Pharmacy from the University of Manitoba and an MBA from McMaster University, Michael G. DeGroote School of Business.
Mr. Fournier holds a Bachelor’s degree in Accounting, B.B.A., from Hautes Études Commerciales Montréal. He is also a member of the Ordre des comptables agréés du Québec.
Before joining the team, Neida worked for nearly 9 years with Novartis where she held the role of Global Head of Procurement, Warehousing and Distribution for all their divisions.
Neida holds a Master of Science in Management of Logistics and Production Systems from École des Mines de Nantes and a Bachelor’s degree in Industrial Engineering from Andrés Bello Catholic University of Venezuela.
Sébastien holds a bachelor’s degree from Sherbrooke University in education; which indicates his interest for people’s development.
Simon Tremblay-Larouche has been vice president of Strategy and Innovation since November 2022. He is responsible for implementing Sandoz Canada’s corporate strategy. Prior to joining the Executive Committee at Sandoz, Simon has held strategic management positions in multiple business sectors, including banking, insurance, technology and telecommunications. Having also held strategy and management consulting roles for several years, Simon has had the opportunity to work directly with several presidents and Executive Committees on the key issues of their organizations.
Simon has a Master's degree in Business Administration from HEC Montreal (2009) and a Bachelor's degree in Engineering and Industrial Processes from the Tennessee University of Technology (2002).
Sonia Gallo has held the position of Vice President, Regulatory Affairs at Sandoz Canada since September 2022. Over the past 20 years, she has occupied various roles, starting as a regulatory associate, and has taken on an increasing number of responsibilities at Sandoz (formerly Sabex). In particular, she oversaw clinical, pharmacovigilance, labeling and market access activities. She is also involved in a number of CGPA committees, including Biosimilars Canada and the Scientific Affairs Committee.
Sonia completed her studies at McGill University and obtained her Bachelor of Science - BS, Biochemistry.